Multimodality imaging of hypoxia in preclinical settings

Area of Science:

• Preclinical cancer research
• Medical imaging techniques
• Tumor microenvironment analysis

Background:

• Tumor hypoxia influences cancer aggressiveness, growth, and metastasis.
• Accurate assessment of in situ tumor hypoxia is clinically and fundamentally important.
• Preclinical models are essential for developing and validating hypoxia detection methods.

Purpose of the Study:

• To review diverse preclinical approaches for assessing in situ tumor hypoxia in rodents.
• To evaluate the capabilities and limitations of various imaging modalities.
• To focus on magnetic resonance imaging (MRI) based techniques for quantitative oxygen tension measurement.

Main Methods:

• Review of nuclear imaging, magnetic resonance, and optical imaging modalities.
• Evaluation of sensitivity, spatial/temporal resolution, cost, and feasibility.
• Detailed examination of ¹⁹F MRI oximetry for quantitative pO₂ mapping.

Main Results:

• Current methods offer a compromise between resolution, sensitivity, and practicality.
• Different modalities are suited for specific aspects of tumor pathophysiology.
• ¹⁹F MRI oximetry provides quantitative, spatially resolved pO₂ measurements relevant to radiobiology.

Conclusions:

• Diverse preclinical imaging strategies exist for studying tumor hypoxia.
• ¹⁹F MRI oximetry shows promise for precise, quantitative in vivo oxygen tension assessment.
• Preclinical method acceptance criteria differ from those for clinical biomarkers.